12 research outputs found
Letâs name the evil correctly: covidosis?
Ancelle Thierry. Nommons correctement le mal : la covidose ?. In: Bulletin de l'Académie Vétérinaire de France tome 173 n°1, 2020. pp. 85-88
ĂpidĂ©miologie de terrain. Sept Ă©tudes de cas
2e Ă©ditionNational audienceDepuis plus de trente ans, le cours international dâĂ©pidĂ©miologie appliquĂ©e (IDEA) forme les futurs cadres de la santĂ© publique Ă lâĂ©pidĂ©miologie de terrain. Sa renommĂ©e doit beaucoup aux nombreuses Ă©tudes de cas originales dĂ©veloppĂ©es, testĂ©es et enrichies au fil des annĂ©es. Fruits de lâexpĂ©rience de professionnels de lâĂ©pidĂ©miologie issus dâhorizons divers, elles ont fait dĂ©couvrir les multiples facettes de la pratique de lâĂ©pidĂ©miologie Ă des gĂ©nĂ©rations dâĂ©pidĂ©miologistes.Les sept Ă©tudes de cas prĂ©sentĂ©es ici sont toutes fondĂ©es sur des faits rĂ©els. Elles traitent de problĂ©matiques variĂ©es, de lâinvestigation de toxi-infections alimentaires Ă lâĂ©mergence de nouveaux pathogĂšnes tels que le SRAS, en passant par le dĂ©pistage de la toxoplasmose chez la femme enceinte.Lâouvrage est conçu comme un manuel en deux parties. La premiĂšre rassemble les Ă©noncĂ©s des Ă©tudes de cas, assortis de questions destinĂ©es Ă guider les Ă©tudiants dans la dĂ©marche de rĂ©solution de problĂšmes. La seconde fournit des rĂ©ponses dĂ©taillĂ©es Ă ces questions, des complĂ©ments dâinformation et des commentaires pĂ©dagogiques
Propositions pour un systÚme de surveillance de la toxoplasmose congénitale en France. A partir d'une étude pilote menée à l'hÎpital Cochin, Paris
PARIS-BIUM (751062103) / SudocCentre Technique Livre Ens. Sup. (774682301) / SudocSudocFranceF
Risk factors for imported fatal Plasmodium falciparum malaria, France 1996-2003
Plasmodium falciparum malaria is a serious health hazard for travelers to malaria-endemic areas and is often diagnosed on return to the country of residence. We conducted a retrospective study of imported falciparum malaria among travelers returning to France from malaria-endemic areas from 1996 through 2003. Epidemiologic, clinical, and parasitologic data were collected by a network of 120 laboratories. Factors associated with fatal malaria were identified by logistic regression analysis. During the study period, 21,888 falciparum malaria cases were reported. There were 96 deaths, for a case-fatality rate of 4.4 per 1,000 cases of falciparum malaria. In multivariate analysis, risk factors independently associated with death from imported malaria were older age, European origin, travel to East Africa, and absence of chemoprophylaxis. Fatal imported malaria remains rare and preventable. Pretravel advice and malaria management should take into account these risk factors, particularly for senior traveler
Evolution of macroprolactinomas during pregnancy: A cohort study of 85 pregnancies
International audienc
Severe Imported Plasmodium falciparum Malaria, France, 1996â2003
Little is known about severe imported Plasmodium falciparum malaria in industrialized countries where the disease is not endemic because most studies have been case reports or have included <200 patients. To identify factors independently associated with the severity of P. falciparum, we conducted a retrospective study using surveillance data obtained from 21,888 P. falciparum patients in France during 1996â2003; 832 were classified as having severe malaria. The global case-fatality rate was 0.4% and the rate of severe malaria was â3.8%. Factors independently associated with severe imported P. falciparum malaria were older age, European origin, travel to eastern Africa, absence of chemoprophylaxis, initial visit to a general practitioner, time to diagnosis of 4 to 12 days, and diagnosis during the fallâwinter season. Pretravel advice should take into account these factors and promote the use of antimalarial chemoprophylaxis for every traveler, with a particular focus on nonimmune travelers and elderly persons
Personal protection against biting insects and ticks.
International audienceRecent events with the first cases of local transmission of chikungunya and dengue fever virus in southern France by Aedes albopictus, adding to the nuisance and potential vectors that can be encountered when traveling in tropical or sub-tropical countries, has shown the value of a reflection on the Personal protection against vectors (PPAV). It is seen during an outbreak of vector-borne disease, or simply because of nuisance arthropods, that our fellow citizens try to protect themselves individually by using an arsenal of resources available on the market. Yet most of these means have been neither checked for effectiveness or safety tests, however, essential. Travellers, staff on mission or assignment, are looking for specific information on how to protect themselves or their families. Health workers had at their disposal so far indications that vary widely from one source to another. Therefore it seemed important to the Society of Travel Medicine (SMV) and the French Society of Parasitology (SFP) to initiate a reflection on this theme. This reflection took the form of recommendations for good practice, following the outline established by the French High Health Authority (HAS). The aim was to gather all relevant information, verified and validated and the format to be used not only by health personnel (doctors, pharmacists, nurses), but also by travel agents and individuals. This document highlights the need to take into account the risk of vector-borne diseases, some deadly, and the benefit of various methods of personal protection. The choice of methods is clearly oriented towards those whose effectiveness has been proven and potential risks assessed. The paper finally proposes two decision trees based on the transmission type (day or night) and kind of stay (short or roaming, long and steady). It concerns travellers, but also expatriates, residents and nomads